[Form 4] Advanced Micro Devices Insider Trading Activity
Rhea-AI Filing Summary
Insider grants reported for AMD (AMD): Ava Hahn, SVP, General Counsel & Corporate Secretary, was granted equity awards on 08/15/2025 as reported on Form 4. The filing shows an option grant for 8,698 shares with an exercise price of $177.51 and an 08/15/2032 expiration, vesting 25% on 08/15/2026 and quarterly thereafter through 08/15/2029. In addition, 12,836 performance-based RSUs (PRSUs) and 4,278 RSUs were awarded, both granted 08/15/2025 and held directly. The PRSUs may pay out between 0% and 250% of target based on relative stock performance, absolute stock return, and a 2027 vs. 2025 non-GAAP EPS metric; final payout and settlement timing will be determined by the Compensation and Leadership Resources Committee.
Positive
- Performance-based PRSUs align executive pay with long-term stock and earnings performance (0%–250% payout range)
- Time-based vesting for options and RSUs through 2028–2029 supports retention
- No disposals reported; holdings increased via awards, indicating no immediate insider selling pressure
Negative
- Uncertain dilution because PRSU payout could reach up to 250% of target, increasing potential share issuance
- Exercise price of $177.51 may be above current market price at grant (not stated in filing), affecting option value until stock rises
- Final PRSU payout subject to committee discretion, creating uncertainty about ultimate award size and timing
Insights
TL;DR: Routine executive compensation aligned with multi-year performance objectives; payout contingent on strong relative and absolute performance.
The grants combine time-based stock options and RSUs with performance-based RSUs tied to multi-year stock and non-GAAP EPS targets, which aligns executive incentives with long-term shareholder outcomes. The option strike of $177.51 establishes a clear performance hurdle relative to market price at grant. The PRSU payout range (0%–250%) creates significant upside for outperformance but also means actual dilution is uncertain until committee determination. Vesting schedules extend to 2028–2029, encouraging retention. Overall this is a standard, performance-heavy package rather than a one-time cash event.
TL;DR: Non-derivative holdings increase via direct awards; no dispositions reported, so no immediate selling pressure indicated.
The Form 4 reports acquisitions only: an option, PRSUs and RSUs, all reported as direct ownership. There are no sales or transfers disclosed. The exercise date and expiration of the option and the multi-year vesting reduce short-term liquidity from this holder. From a trading-impact perspective, these awards are unlikely to produce near-term share supply since vesting and performance determination span years and settlement appears deferred until performance/vesting completion.